ViaNautis Bio
PrivateLast Round
Series A
Nov 13, 2023
Total Funding Raised
$27.89M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
ViaNautis Bio is a biotechnology company developing a nanomedicine platform to deliver genetic therapies across biological barriers for diseases such as cystic fibrosis and central nervous system disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ViaNautis Bio Comparables
Compare ViaNautis Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genedit | 88% | |
| Nanite, Inc. | 84% | |
| Deliver Biosciences | 80% |
ViaNautis Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 13, 2023 | ||||
| Seed | Mar 29, 2021 |
Key People
Founding team and executive leadership
ViaNautis Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| UCB Ventures | Series A |
| BGF | Series A |
| Origin Capital | Series A, Seed |
| o2h ventures | Series A, Seed |
| 4BIO Capital | Series A |
| Meltwind Advisory | Series A, Seed |
| Cystic Fibrosis Foundation | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 181% MoM, reaching 1.6K.
- Mar 13, 2025
Grew 18% QoQ, from 38 to 45 employees.
Recent news
Latest coverage and updates
- is_developingSep 9, 2026
ViaNautis Bio Ltd. is developing polyNaut, a delivery platform on Sep 9th '26.
ViaNautis Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ViaNautis Bio's valuation, stock price, and market status.
Is ViaNautis Bio a public or private company?
ViaNautis Bio is a private company.
What is the current stock price of ViaNautis Bio?
ViaNautis Bio is a private company with no public stock price. No recent secondary market data is available.
How much is ViaNautis Bio worth (valuation)?
Valuation information for ViaNautis Bio is not publicly available.
Can I buy ViaNautis Bio stock?
ViaNautis Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ViaNautis Bio's last funding round?
ViaNautis Bio's most recent funding round was Series A on November 13, 2023.
Who are the main investors in ViaNautis Bio?
Key investors in ViaNautis Bio include UCB Ventures, BGF, Origin Capital, 4Bio Capital, Meltwind Advisory.
Will ViaNautis Bio IPO soon?
No public IPO plans have been announced for ViaNautis Bio.
How can I track ViaNautis Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ViaNautis Bio's secondary market activity and sign up for updates.